Clinical Trial Update: Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether bispectral index monitoring improves sedation management with midazolam and meperidine during endoscopic submucosal dissection i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenoma
• Gastric Cancer

Drugs mentioned

• Meperidine (Meperidine)
• Midazolam (Midazolam)

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Adenoma, Gastric Cancer | Phase 3 | Status: UNKNOWN